Philippe van de Borne
Université Libre de Bruxelles
H-index: 63
Europe-Belgium
Top articles of Philippe van de Borne
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Altered Left Ventricular Rat Gene Expression Induced by the Myosin Activator Omecamtiv Mecarbil | Genes | Bachar El Oumeiri Laurence Dewachter Philippe Van de Borne Géraldine Hubesch Christian Melot | 2023/1/1 |
Non-invasive cardiac kinetic energy distribution: A new marker of heart failure with impaired ejection fraction (KINO-HF) | Archives of Cardiovascular Diseases Supplements | E De Keyzer A Hossein J Rabineau M Morissens A Almorad | 2023/1/1 |
Cardiovascular deconditioning and impact of artificial gravity during 60-day head-down bed rest—Insights from 4D flow cardiac MRI | Frontiers in Physiology | Jeremy Rabineau Margot Issertine Fabian Hoffmann Darius Gerlach Enrico G Caiani | 2022/10/7 |
Involvement of the chemerin-ChemR23 system in severe COVID-19 patients | P Lavis S Morra C Orte Cano N Albayrak V Corbière | 2022/9/4 | |
HYPERTENSION IN CAMEROONIAN RURAL AND URBAN PYGMIES AND BANTUS OF THE SOUTHERN REGION | Journal of Hypertension | Yves Hako Claude Bika Cecile Okala Jean Ii Dissongo Jean-René M’buyamba Kabangu | 2022/6/1 |
SP-D and CC-16 pneumoproteins' kinetics and their predictive role during SARS-CoV-2 Infection | Frontiers in Medicine | Margherita Tiezzi Sofia Morra Jimmy Seminerio Alain Van Muylem Audrey Godefroid | 2022/2/8 |
Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study | Acta Cardiologica | Philippe van de Borne André Peeters Luc Janssens Attilio Leone Robin Lemmens | 2022/4/15 |
Assessment of Intracoronary Adenosine-Induced Hyperemia in Patients with Atrial Fibrillation in Comparison with Patients in Sinus Rhythm | Cardiology | Georgiana Pintea Bentea Brahim Berdaoui Sophie Samyn Marielle Morissens Philippe Van de Borne | 2022 |
Detection of soluble suppression of tumorigenicity 2 and N-terminal B-type natriuretic peptide in a rat model of aortic regurgitation: differential responses to omecamtiv mecarbil | Journal of Basic and Clinical Physiology and Pharmacology | Bachar El Oumeiri Philippe van de Borne Géraldine Hubesch Pascale Jespers Laurence Dewachter | 2022/11/1 |
Investigating Cardiorespiratory Interaction Using Ballistocardiography and Seismocardiography—A Narrative Review | Paniz Balali Jeremy Rabineau Amin Hossein Cyril Tordeur Olivier Debeir | 2022/12/6 | |
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc … | The Lancet Diabetes & Endocrinology | Subodh Verma Nitish K Dhingra Javed Butler Stefan D Anker Joao Pedro Ferreira | 2022/1/1 |
Effort perception and hemodynamic responses to the 3/7 vs. 3X9 methods in heart failure and in coronary artery disease patients: a randomized-cross-over study | European Journal of Preventive Cardiology | A Gillet M Lamotte K Forton A Roussoulieres C Dewachter | 2022/5 |
Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality | Frontiers in immunology | Philomène Lavis Sofia Morra Carmen Orte Cano Nurhan Albayrak Véronique Corbière | 2022/8/12 |
Value of repeated measurements of lipoprotein (a) to assess cardiovascular risk: a retrospective study | Acta Cardiologica | Axelle Deconinck Sofia Morra Nina Glassée Philippe van de Borne | 2022/1/25 |
Association of Amlodipine with the Risk of In-Hospital Death in Patients with COVID-19 and Hypertension: A Reanalysis on 184 COVID-19 Patients with Hypertension | Pharmaceuticals | Gwenolé Loas Philippe Van de Borne Gil Darquennes Pascal Le Corre | 2022/3/21 |
Beta-Adrenergic Receptor Blockade Effects on Cardio-Pulmonary Exercise Testing in Healthy Young Adults: A Randomized, Placebo-Controlled Trial | Sports Medicine-Open | Kevin Forton Michel Lamotte Alexis Gillet Martin Chaumont Philippe Van De Borne | 2022/12 |
Benefits of Cardio-Pulmonary Rehabilitation in Moderate to Severe Forms of COVID-19 Infection | Healthcare | Clara Douin Kevin Forton Michel Lamotte Alexis Gillet Philippe Van de Borne | 2022/10/17 |
ATHERO: AN OBSERVATIONAL CROSS-SECTIONAL EVALUATION OF ATHEROSCLEROTIC RISK CONTROL IN THE BELGIAN POPULATION TREATED WITH AT LEAST ONE ANTIHYPERTENSIVE AND ONE LIPID-LOWERING DRUG | Journal of hypertension | Ernst Rietzschel Olivier Descamps Johan De Sutter Jean-Christophe Philips Philippe van de Borne | 2022/6/1 |
Zofenopril: Blood pressure control and cardio-protection | Cardiology Journal | Claudio Borghi Giuseppe Ambrosio Philippe Van De Borne Giuseppe Mancia | 2022 |
SERUM PROTEOME AND HIGH WATTAGE E-CIGARETTE VAPING: A RANDOMIZED CROSSOVER STUDY | Journal of Hypertension | Martin Chaumont David Communi Vanessa Tagliatti Jean-Marie Colet Philippe Van de Borne | 2021/4/1 |
